4
Changes in Ownership
Evofem Biosciences, Inc. Filed Acc 0001209191-15-013100
Options or other derivatives
- VP, Pharma Dev & Manufacturing acquired 42,350 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kemmerer Christopher VP, Pharma Dev & Manufacturing | 2015-02-10 | Grant or award · Stock Option (Right to Buy) | +42,350 | 42,350 | D | ||
Loading xslF345X03/doc4.xml…